AlphaMol Overview
- Year Founded
-
2020
- Status
-
Private
- Latest Deal Type
-
Later Stage VC
- Investors
-
8
AlphaMol General Information
Description
Developer of biological computing technologies intended to speed up modern drug discovery. The company's technologies integrated computation biology, artificial intelligence, and other new technologies in experimental drug screening to develop front-end biological computing methods, coupled with originally innovative biotechnologies, enabling customers in the medical industry to expedite the screening and designing of potent drug candidates.
Contact Information
Website
www.alphamol.comCorporate Office
- Room 3605, Block A, Zhongguan Plaza
- Number 4168 Liuxian Boulevard
- Shenzhen, Guangdong 201210
- China
Corporate Office
- Room 3605, Block A, Zhongguan Plaza
- Number 4168 Liuxian Boulevard
- Shenzhen, Guangdong 201210
- China
AlphaMol Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC | 17-Nov-2025 | Completed | Generating Revenue | |||
| 4. Secondary Transaction - Private | 08-Sep-2023 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series A) | 24-Aug-2023 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 25-Nov-2022 | Completed | Generating Revenue | |||
| 1. Seed Round | 07-May-2021 | Completed | Startup |
AlphaMol Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Shanghai Healthcare Capital | PE/Buyout | Minority | ||
| Shenzhen Huaqian Equity Investment Fund Management | Venture Capital | Minority | ||
| ApicHope Pharmaceutical Group | Corporation | Minority | ||
| Invengo Information Technology Company | Corporation | Minority | ||
| New Value Capital (China) | Venture Capital | Minority |
AlphaMol Investments (1)
AlphaMol’s most recent deal was a Early Stage VC with Essentia BioSciences for . The deal was made on 01-Jan-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Essentia BioSciences | 01-Jan-2026 | Early Stage VC | Biotechnology |
AlphaMol FAQs
-
When was AlphaMol founded?
AlphaMol was founded in 2020.
-
Where is AlphaMol headquartered?
AlphaMol is headquartered in Shenzhen, China.
-
What industry is AlphaMol in?
AlphaMol’s primary industry is Drug Discovery.
-
Is AlphaMol a private or public company?
AlphaMol is a Private company.
-
What is AlphaMol’s current revenue?
The current revenue for AlphaMol is .
-
Who are AlphaMol’s investors?
Shanghai Healthcare Capital, Shenzhen Huaqian Equity Investment Fund Management, ApicHope Pharmaceutical Group, Invengo Information Technology Company, and New Value Capital (China) are 5 of 8 investors who have invested in AlphaMol.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process